Logo image of PINK.CA

PERIMETER MEDICAL IMAGING AI (PINK.CA) Stock Fundamental Analysis

TSX-V:PINK - TSX Venture Exchange - CA71385D1078 - Common Stock - Currency: CAD

0.54  -0.01 (-1.82%)

Fundamental Rating

3

PINK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 15 industry peers in the Health Care Equipment & Supplies industry. PINK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, PINK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PINK had negative earnings in the past year.
In the past year PINK has reported a negative cash flow from operations.
In the past 5 years PINK always reported negative net income.
PINK had a negative operating cash flow in each of the past 5 years.
PINK.CA Yearly Net Income VS EBIT VS OCF VS FCFPINK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -98.99%, PINK perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
The Return On Equity of PINK (-121.13%) is better than 64.29% of its industry peers.
Industry RankSector Rank
ROA -98.99%
ROE -121.13%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PINK.CA Yearly ROA, ROE, ROICPINK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

PINK has a better Gross Margin (59.45%) than 71.43% of its industry peers.
PINK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PINK.CA Yearly Profit, Operating, Gross MarginsPINK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50K -100K

More info and screens

5

2. Health

2.1 Basic Checks

PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for PINK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PINK.CA Yearly Shares OutstandingPINK.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M
PINK.CA Yearly Total Debt VS Total AssetsPINK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -3.29, we must say that PINK is in the distress zone and has some risk of bankruptcy.
PINK has a Altman-Z score (-3.29) which is in line with its industry peers.
A Debt/Equity ratio of 0.01 indicates that PINK is not too dependend on debt financing.
The Debt to Equity ratio of PINK (0.01) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -3.29
ROIC/WACCN/A
WACC7.93%
PINK.CA Yearly LT Debt VS Equity VS FCFPINK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M

2.3 Liquidity

PINK has a Current Ratio of 4.98. This indicates that PINK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.98, PINK belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
PINK has a Quick Ratio of 4.97. This indicates that PINK is financially healthy and has no problem in meeting its short term obligations.
PINK has a Quick ratio of 4.97. This is amongst the best in the industry. PINK outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 4.98
Quick Ratio 4.97
PINK.CA Yearly Current Assets VS Current LiabilitesPINK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for PINK have decreased strongly by -56.32% in the last year.
The Revenue has grown by 61.14% in the past year. This is a very strong growth!
EPS 1Y (TTM)-56.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1254.72%
Revenue 1Y (TTM)61.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%81.22%

3.2 Future

Based on estimates for the next years, PINK will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.22% on average per year.
PINK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 106.53% yearly.
EPS Next Y16.12%
EPS Next 2Y2.32%
EPS Next 3Y7.1%
EPS Next 5Y9.22%
Revenue Next Year14.85%
Revenue Next 2Y106.36%
Revenue Next 3Y129.71%
Revenue Next 5Y106.53%

3.3 Evolution

PINK.CA Yearly Revenue VS EstimatesPINK.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
PINK.CA Yearly EPS VS EstimatesPINK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 0.4 0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PINK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PINK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PINK.CA Price Earnings VS Forward Price EarningsPINK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PINK.CA Per share dataPINK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.32%
EPS Next 3Y7.1%

More info and screens

0

5. Dividend

5.1 Amount

PINK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERIMETER MEDICAL IMAGING AI

TSX-V:PINK (3/7/2025, 7:00:00 PM)

0.54

-0.01 (-1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-14 2024-11-14
Earnings (Next)03-26 2025-03-26/amc
Inst Owners33.18%
Inst Owner ChangeN/A
Ins Owners13.82%
Ins Owner ChangeN/A
Market Cap50.50M
Analysts80
Price Target2.04 (277.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)35%
Min Revenue beat(2)3.17%
Max Revenue beat(2)66.83%
Revenue beat(4)2
Avg Revenue beat(4)-10.17%
Min Revenue beat(4)-76.02%
Max Revenue beat(4)66.83%
Revenue beat(8)3
Avg Revenue beat(8)-19.87%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)17.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-20%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 56.29
P/FCF N/A
P/OCF N/A
P/B 2.75
P/tB 2.75
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.01
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -98.99%
ROE -121.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.45%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.33%
Cap/Sales 60.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.98
Quick Ratio 4.97
Altman-Z -3.29
F-Score3
WACC7.93%
ROIC/WACCN/A
Cap/Depr(3y)853.35%
Cap/Depr(5y)N/A
Cap/Sales(3y)6728.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1254.72%
EPS Next Y16.12%
EPS Next 2Y2.32%
EPS Next 3Y7.1%
EPS Next 5Y9.22%
Revenue 1Y (TTM)61.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%81.22%
Revenue Next Year14.85%
Revenue Next 2Y106.36%
Revenue Next 3Y129.71%
Revenue Next 5Y106.53%
EBIT growth 1Y-78.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-49.14%
EBIT Next 3Y-22.75%
EBIT Next 5Y-6.55%
FCF growth 1Y18.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.9%
OCF growth 3YN/A
OCF growth 5YN/A